FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 60 filers reported holding FATE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,719 | -40.9% | 8,358 | +32.8% | 0.00% | 0.0% |
| Q2 2023 | $29,959 | -16.5% | 6,294 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $35,876 | +2.7% | 6,294 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $34,932 | -75.2% | 6,294 | 0.0% | 0.00% | -83.3% |
| Q3 2022 | $141,000 | -9.0% | 6,294 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $155,000 | -36.5% | 6,294 | 0.0% | 0.01% | -22.2% |
| Q1 2022 | $244,000 | -33.7% | 6,294 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $368,000 | -1.3% | 6,294 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $373,000 | -31.7% | 6,294 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $546,000 | +6.8% | 6,294 | +1.6% | 0.02% | +5.3% |
| Q1 2021 | $511,000 | -6.4% | 6,194 | +3.2% | 0.02% | -24.0% |
| Q4 2020 | $546,000 | +123.8% | 6,000 | -1.7% | 0.02% | +127.3% |
| Q3 2020 | $244,000 | +28.4% | 6,104 | +10.3% | 0.01% | +22.2% |
| Q2 2020 | $190,000 | +63.8% | 5,533 | +6.1% | 0.01% | +28.6% |
| Q1 2020 | $116,000 | +13.7% | 5,214 | 0.0% | 0.01% | +40.0% |
| Q4 2019 | $102,000 | +47.8% | 5,214 | +17.5% | 0.01% | +66.7% |
| Q3 2019 | $69,000 | -23.3% | 4,438 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $90,000 | +2.3% | 4,438 | -11.8% | 0.00% | 0.0% |
| Q1 2019 | $88,000 | +66.0% | 5,030 | +22.7% | 0.00% | +33.3% |
| Q4 2018 | $53,000 | -20.9% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $67,000 | +45.7% | 4,100 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $46,000 | +15.0% | 4,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $40,000 | +100.0% | 4,100 | +22.5% | 0.00% | +100.0% |
| Q4 2017 | $20,000 | +66.7% | 3,346 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $12,000 | +9.1% | 3,346 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $11,000 | – | 3,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |